Northwest & Ethical Investments L.P. Biogen Inc. Transaction History

Northwest & Ethical Investments L.P.

$4.03 Trillion
Q2 2025

A detailed history of Northwest & Ethical Investments L.P. transactions in Biogen Inc. stock. As of the latest transaction made, Northwest & Ethical Investments L.P. holds 2,000 shares of BIIB stock, worth $293,260. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,000

Previous 2,000 -0.0%

Holding current value

$293,260

Previous $274 Million 8.22%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$146.47 - $191.55 $795,039 - $1.04 Million	-5,428 Reduced 73.07%	2,000 $306 Million
Q3 2024 Nov 13, 2024	SELL	$189.07 - $236.8 $215,350 - $269,715	-1,139 Reduced 13.3%	7,428 $1.44 Billion
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $1.63 Million - $2.03 Million	8,567 New	8,567 $1.99 Billion
Q1 2024 Jul 09, 2025	BUY	$212.02 - $267.71 $1.39 Million - $1.76 Million	6,567 Added 328.35%	8,567 $1.85 Billion
Q3 2020 Jul 08, 2025	SELL	$264.77 - $305.71 $1.35 Million - $1.56 Million	-5,109 Closed	0 $0
Q2 2020 Jul 08, 2025	SELL	$258.66 - $342.55 $395,749 - $524,101	-1,530 Reduced 23.05%	5,109 $1.37 Billion
Q1 2020 Jul 08, 2025	SELL	$268.85 - $341.04 $26,885 - $34,104	-100 Reduced 1.48%	6,639 $2.1 Billion
Q4 2019 Jul 08, 2025	SELL	$220.06 - $304.07 $1.22 Million - $1.68 Million	-5,525 Reduced 45.05%	6,739 $2 Billion
Q3 2019 Jul 08, 2025	SELL	$217.44 - $243.88 $905,855 - $1.02 Million	-4,166 Reduced 25.36%	12,264 $2.86 Billion
Q2 2019 Jul 08, 2025	SELL	$219.29 - $241.72 $37,279 - $41,092	-170 Reduced 1.02%	16,430 $3.84 Billion
Q1 2019 Jul 08, 2025	SELL	$216.71 - $338.96 $1.68 Million - $2.63 Million	-7,764 Reduced 31.87%	16,600 $3.92 Billion
Q4 2018 Jul 08, 2025	BUY	$278.5 - $352.75 $6.23 Million - $7.89 Million	22,364 Added 1118.2%	24,364 $7.33 Billion
Q3 2018 Jul 08, 2025	BUY	$293.51 - $383.83 $4.46 Million - $5.84 Million	15,212 New	15,212 $5.37 Billion
Q2 2018 Jul 08, 2025	SELL	$257.52 - $306.91 $77,256 - $92,073	-300 Closed	0 $0
Q4 2017 Jul 08, 2025	SELL	$307.64 - $344.58 $1.08 Million - $1.21 Million	-3,500 Reduced 92.11%	300 $95.6 Million
Q3 2017 Jul 08, 2025	BUY	$281.15 - $329.69 $1 Million - $1.17 Million	3,563 Added 1503.38%	3,800 $1.19 Billion
Q1 2017 Jul 08, 2025	BUY	N/A	100 Added 72.99%	237 $64.8 Million
Q4 2016 Jul 08, 2025	SELL	N/A	-1,863 Reduced 93.15%	137 $38.9 Million
Q2 2015 Jul 08, 2025	BUY	N/A	6,500	8,500 $3.43 Billion

Others Institutions Holding BIIB

# of Institutions

1,022

Shares Held

131M

Call Options Held

2.84M

Put Options Held

2.57M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest & Ethical Investments L.P., based on Form 13F filings with the SEC.

News

Stay updated on Northwest & Ethical Investments L.P. with notifications on news.

Account

Northwest & Ethical Investments L.P. Biogen Inc. Transaction History